These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32250198)

  • 41. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
    Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
    Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
    Rutten FH
    Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency of β-Blocker Use Following Exacerbations of COPD in Patients with Compelling Indication for Use.
    Pinner N; Oliver W; Veasey T; Starr J; Eudaley S; Hutchison A; Wargo K
    South Med J; 2019 Nov; 112(11):586-590. PubMed ID: 31682740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
    Matera MG; Martuscelli E; Cazzola M
    Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.
    Neef PA; Burrell LM; McDonald CF; Irving LB; Johnson DF; Steinfort DP
    Intern Med J; 2017 Sep; 47(9):1043-1050. PubMed ID: 28608512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta blockers as anti-arrhythmic agents.
    Anh D; Marine JE
    Heart Fail Rev; 2004 Apr; 9(2):139-47. PubMed ID: 15516862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment].
    Rasmussen DB; Lange P; Jensen MT
    Ugeskr Laeger; 2015 Sep; 177(38):V02150184. PubMed ID: 26376419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of beta-blocker therapy on clinical outcomes, safety, health-related quality of life and functional capacity in patients with chronic obstructive pulmonary disease (COPD): a protocol for a systematic literature review and meta-analysis with multiple treatment comparison.
    Gulea C; Zakeri R; Quint JK
    BMJ Open; 2018 Nov; 8(11):e024736. PubMed ID: 30429149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.
    De Freitas O; Lenz O; Fornoni A; Materson BJ
    Vasc Health Risk Manag; 2006; 2(2):139-44. PubMed ID: 17319457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. β-blockers in COPD - yes, it's OK (with care).
    Bryant L
    J Prim Health Care; 2012 Jun; 4(2):165. PubMed ID: 22852168
    [No Abstract]   [Full Text] [Related]  

  • 51. Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study.
    Rasmussen DB; Bodtger U; Lamberts M; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
    Thorax; 2020 Nov; 75(11):928-933. PubMed ID: 32820080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of beta-blockers in congestive heart failure.
    Sallach JA; Goldstein S
    Ann Med; 2003; 35(4):259-66. PubMed ID: 12846268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardioselective beta-blockers for reversible airway disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2002; (4):CD002992. PubMed ID: 12519582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison.
    Gulea C; Zakeri R; Alderman V; Morgan A; Ross J; Quint JK
    Respir Res; 2021 Feb; 22(1):64. PubMed ID: 33622362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical studies on beta blockers and heart failure preceding the MERIT-HF Trial. Metoprolol CR/XL Randomized Intervention Trial in Heart Failure.
    Goldstein S
    Am J Cardiol; 1997 Nov; 80(9B):50J-53J. PubMed ID: 9375951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
    Salpeter SR; Ormiston TM; Salpeter EE; Poole PJ; Cates CJ
    Respir Med; 2003 Oct; 97(10):1094-101. PubMed ID: 14561016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
    Pescaru C; Tudorache V; Oancea C
    Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic obstructive pulmonary disease and β-blocker treatment in Asian patients with heart failure.
    Kubota Y; Tay WT; Asai K; Murai K; Nakajima I; Hagiwara N; Ikeda T; Kurita T; Teng TK; Anand I; Lam CSP; Shimizu W;
    ESC Heart Fail; 2018 Apr; 5(2):297-305. PubMed ID: 29055972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.